About Meridian Bioscience
Meridian Bioscience is a Healthcare company based in United States founded in 1976, and was acquired by SJL Partners in July 2022. Molecular diagnostic device and kits. Meridian Bioscience has completed 5 acquisitions, including Bioline, Exalenz Bioscience and GenePOC Diagnostics. Its chief executive, as recorded, is Jack Kenny. Its website meridianbioscience.com draws about 32 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is MERIDIAN BIOSCIENCE INC. Its competitors include OriGene, Teknova and Cayman Chem; 1 of its 3 listed competitors has raised funding.
Company details
Meridian Bioscience, is a life science company that develops, manufactures, markets, and distributes a broad range of diagnostic test kits for infectious diseases, purified reagents, and related products and offers biopharmaceutical enabling technologies. The companys proprietary product illumigene is a portable molecular diagnostic system that allows the detection of C. difficile, GroupA B Streptococcus, HSV 1 2 Mycoplasma, and Pertussis. In addition, Meridian is a supplier of rare reagents, specialty biologicals, and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines
- Headquarters Ohio, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website meridianbioscience.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by SJL Partners (Jul 2022)
- Legal Name Meridian Bioscience Inc
- Latest Funding Round$5.5M (USD), Grant
Feb 2021
- InvestorsNIH
& 3 more
- Investments & AcquisitionsBioline
& 4 more
- Acquired bySJL Partners
(Jul 2022)
Apps and channels of Meridian Bioscience
its YouTube channel Meridian Bioscience has 438 subscribers and 30 videos.
Videos from Meridian Bioscience
The most watched videos on Meridian Bioscience's YouTube channel, Meridian Bioscience (438 subscribers). Click a video to play it here.
More on Meridian Bioscience.
Funding Insights of Meridian Bioscience
- Total Rounds 2
- Last Round Grant — $5.5M
- First Round $1M
(Dec 2020)
- Investors Count 2
All 2 funding rounds of Meridian Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
4 investors in total: 4 institutional.
Investors in Meridian Bioscience
Meridian Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, SD Biosensor and JobsOhio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cross-border investments are managed by SJL Partners in key regions. | sjlpartners.com | Seoul, Korea | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
JobsOhio is focused on economic development in Ohio. | jobsohio.com | Columbus, United States | ||
Biosensors for point-of-care diagnostics are developed by SD Biosensor. | 2001 | sdbiosensor.com | Suwon-si, South Korea |
Investor details for Meridian Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Meridian Bioscience
145 people are tracked at Meridian Bioscience (36 in leadership, 5 in board & advisors, 104 in team).
| Name | Role | Group |
|---|---|---|
Jack Kenny | CEO | Leadership |
Allison Graham | Senior Director, Strategic Marketing & Planning | Leadership |
Michael Baez | Director Of Distribution, Americas | Leadership |
Lance Connor | Senior Director Of Customer Service And Business Management | Leadership |
Matt Reynolds | Director Of Operations And Site Leader | Leadership |
Todd Woodrich | Sr. Director Of Operations | Leadership |
Michelle Bosch | Vice President, Global Commercial Marketing And Business Management | Leadership |
Lorraine de Beer | Director, Sales And Marketing EMEA And APAC | Leadership |
Cqa Katie Sullivan | Director, Quality Operations | Leadership |
Julie Smith | Senior Vice President Controller & Principal Accounting Officer | Leadership |
Cheryl Paes | Head Of Marketing- Life Science | Leadership |
Alison W. | Talent Acquisition Partner | Leadership |
Florent Chang-Pi-Hin | Vice President R&d, Life Science - UK Site Leader | Leadership |
Lindsay K Harmon | Director, Commercial Training And Development | Leadership |
Denis Roy | Senior Director, R&d | Leadership |
Wes Lindsey Mba | Vice President, Global Research & Development And Clinical Affairs | Leadership |
Andy Kitzmiller | EVP, CFO | Leadership |
Lourdes G. Weltzien | President, Life Science | Leadership |
Michael Lachance | Senior Director, Finance - Global Life Science | Leadership |
Catherine Lufkin | Senior Director, Global Point Of Care | Leadership |
125 more people are available in the full profile.
Complete people profiles for Meridian Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Meridian Bioscience
Meridian Bioscience has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Bioline, Exalenz Bioscience and GenePOC Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Breath gas analysis to detect H pylori infection and diagnose Gastric and hepatocellular cancer | exalenz.com | 2006 | Feb 2020 | $49M | ||
Point-of-care nucleic acid assays for infectious diseases are developed rapidly. | genepoc-diagnostics.com | Quebec, Canada | 2007 | Apr 2019 | •••• | |
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications | magellanbioscience.com | Tampa, United States | 1997 | Mar 2016 | $66M | |
Point-of-care platforms for heavy metal toxicity diagnostics are developed. | magellandx.com | Billerica, United States | 1968 | Mar 2016 | $66M | |
Bioline is engaged in providing reagents for molecular biology research. | bioline.com | London, United Kingdom | 1992 | Jul 2010 | $23.3M |
Complete acquisition details for Meridian Bioscience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Meridian Bioscience
10 dated milestones of Meridian Bioscience across 46 years, from founding to its latest funding, stage changes and deals.
- Founded Meridian Bioscience is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Bioline.
- Acquisition Acquires Magellan Diagnostics.
- Acquisition Acquires Magellan BioScience Group.
- Acquisition Acquires GenePOC Diagnostics.
- Acquisition Acquires Exalenz Bioscience.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $5.5M.
- Exit Acquired by SJL Partners.
Competitors of Meridian Bioscience
Meridian Bioscience has 3 listed competitors in our database, 1 of them funded. They include OriGene, Teknova and Cayman Chem.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| teknova.com | 1996 | Hollister, United States | 290 | Molecular biology reagents and kits are supplied for research applications. | ||
| caymanchem.com | 1980 | Ann Arbor, United States | 309 | Bioreagents and assay kits are developed, with preclinical services provided. |
Detailed competitors of Meridian Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Meridian Bioscience
The website of Meridian Bioscience (meridianbioscience.com) receives about 31.9K visits a month.
- Monthly visits31.9K
▲ 27.2% vs previous month
Websites whose visitors overlap most with Meridian Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| quidel.com | 100% | #5,902,749 | View details | ||
| bd.com | 99% | 1.2M | #57,463 | View details | |
| savyondiagnostics.com | 82% | #6,468,038 | View details | ||
| questdiagnostics.com | 79% | 14.4M | #2,905 | View details | |
| abaxis.com | 78% | 2.2K | #7,093,547 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 31 similar websites and full traffic analytics for Meridian Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 31 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Meridian Bioscience (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Meridian Bioscience
Complete news archive for Meridian Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meridian Bioscience
Meridian Bioscience was founded in 1976 and raised its 1st funding round 44 years after it was founded.
Meridian Bioscience is headquartered in United States. It is registered at Ohio, United States.
Jack Kenny is the CEO of Meridian Bioscience, as recorded in our data.
Meridian Bioscience, is a life science company that develops, manufactures, markets, and distributes a broad range of diagnostic test kits for infectious diseases, purified reagents, and related products and offers biopharmaceutical enabling technologies. The companys proprietary product illumigene is a portable molecular diagnostic system that allows the detection of C. difficile, GroupA B Streptococcus, HSV 1 2 Mycoplasma, and Pertussis. In addition, Meridian is a supplier of rare reagents, specialty biologicals, and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines.
Meridian Bioscience's top competitors include Cayman Chem, Teknova and OriGene.
Meridian Bioscience has made 5 acquisitions, including Bioline, Exalenz Bioscience, and GenePOC Diagnostics.
Meridian Bioscience has 4 investors. Key investors include NIH, SD Biosensor, JobsOhio, and SJL Partners.
Meridian Bioscience operates through Meridian Bioscience Inc.
Yes. Meridian Bioscience was acquired by SJL Partners in July 2022.